Not for distribution in the U.S. or to U.S. newswire services.VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing
- Share purchase agreement further strengthens Company’s position to deliver on value-driving clinical milestones -TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceuti
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California on Tuesday, June 13, 2023,
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Saskatchewan's Global Agri-Food Advancement Partnership (GAAP) recently led and closed an investment round into BioScout Australia along with sector leading investor Artesian (Alternative Investments), and other e
OTTAWA, Ontario--(BUSINESS WIRE)--The Board of Directors at IHA Canada (Innovative Housing Alternatives) announced the appointment of Asif Khan as CEO, Effective May 23, 2023. IHA’s Glengarry Hills Village is an innovative 54-acre land project set for c
Registration for the Patient Safety Movement Foundation’s Anniversary Summit Is ClosedIRVINE, Calif.--(BUSINESS WIRE)--#patientsafety--Registration for the 10th Annual Patient Safety, Science & Technology Summit is now closed. This in-person Summit
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESSASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (AIM/TSXV: GSP), a fertilizer development company
EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the filing of a registration statement on Form S-8 with the United States Securities and Exchange Commission (SEC). Under U.S. federal
Delivered first quarter revenue of $16.1 million, up 4.2% year over year Adjusted EBITDA(1) of $0.7 million, our 17th consecutive quarter of positive adjusted EBITDA Continued focus on operational improvements and new services to better serve our pati
TORONTO--(BUSINESS WIRE)--$HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the tr
Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.